CIK: 0001535610
Total reported value
$45.1M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BIIB | Biogen Inc. | Stock-Healthcare | 11.89% | — | +18.35% | |
| 2 | ✓ | Ishares Tr | Stock-Other | 11.61% | -19.97% | EXIT | |
| 3 | BIIB | Biogen INC | Stock-Healthcare | 8.34% | — | -16.84% | |
| 4 | NVO | Novo Nordisk A/S | Stock-Healthcare | 5.42% | — | — | |
| 5 | SRPT | Sarepta Therapeutics, Inc. | Stock-Healthcare | 5.29% | — | -9.26% | |
| 6 | ✓ | Esperion Therapeutics INC Ne | Stock-Other | 5.18% | — | +15.45% | |
| 7 | NVO | Novo-nordisk A/s-spons Adr | Stock-Healthcare | 3.74% | — | — | |
| 8 | NVO | Novo Nordisk A/S | Stock-Healthcare | 3.46% | — | — | |
| 9 | ✓ | Stock-Other | 2.75% | — | +963.21% | ||
| 10 | ✓ | Spdr Series Trust | Stock-Other | 2.57% | — | — | |
| 11 | ✓ | Odonate Therapeu | Stock-Other | 2.41% | — | -21.20% | |
| 12 | ✓ | Sarepta Therapeutics INC | Stock-Other | 2.27% | — | +2.25% | |
| 13 | AZN | AstraZeneca PLC | Stock-Healthcare | 2.23% | — | -59.84% | |
| 14 | NKTREUR | Nektar Therapeutics | Stock-Other | 2.23% | — | +311.22% | |
| 15 | AZN | AstraZeneca PLC | Stock-Healthcare | 1.81% | — | -81.35% | |
| 16 | XERS | Xeris Biopharma Holdings, Inc. | Stock-Other | 1.61% | — | — | |
| 17 | ✓ | Unum Therapeutics INC | Stock-Other | 1.58% | — | -31.11% | |
| 18 | ✓ | Zogenix INC | Stock-Other | 1.44% | — | -57.55% | |
| 19 | ESPR | Esperion Therapeutics INC | Stock-Other | 1.10% | — | +690.01% | |
| 20 | ✓ | Sangamo Therapeutics INC | Stock-Other | 0.95% | — | +4.55% | |
| 21 | ✓ | Spdr Series Trust | Stock-Other | 0.90% | — | -55.44% | |
| 22 | ✓ | Spark Therapeutics INC | Stock-Other | 0.86% | — | -29.42% | |
| 23 | ✓ | Stock-Other | 0.77% | — | — | ||
| 24 | ✓ | Insmed INC | Stock-Other | 0.74% | — | +205.89% | |
| 25 | ✓ | Global Blood Therapeutics INC | Stock-Other | 0.71% | — | +10.29% | |
| 26 | BCLIEUR | Brainstorm Cell Therapeutics | Stock-Other | 0.69% | — | +4064.87% | |
| 27 | ✓ | Ophthotech Corporation | Stock-Other | 0.68% | — | — | |
| 28 | SSKNEUR | Strata Skin Sciences INC | Stock-Other | 0.65% | — | +432.80% | |
| 29 | ✓ | Amarin Corp PLC | Stock-Other | 0.63% | — | +28.71% | |
| 30 | ✓ | Stock-Other | 0.60% | — | -9.79% | ||
| 31 | ✓ | Stock-Other | 0.60% | — | — | ||
| 32 | ✓ | Oncobiologics INC | Stock-Other | 0.59% | — | +75.16% | |
| 33 | INCY | Incyte CORP | Stock-Healthcare | 0.52% | — | -49.40% | |
| 34 | ✓ | Galmed Pharmaceuticals LTD | Stock-Other | 0.52% | — | — | |
| 35 | ✓ | Aveo Pharmaceuticals INC | Stock-Other | 0.52% | — | +42.50% | |
| 36 | ✓ | Incyte CORP | Stock-Other | 0.51% | — | -68.65% | |
| 37 | AZNN | Astrazeneca Plc-spons Adr | Stock-Other | 0.45% | — | — | |
| 38 | SGMOQ | Sangamo Therapeutics INC | Stock-Other | 0.45% | — | +18.36% | |
| 39 | ✓ | Stock-Other | 0.43% | — | — | ||
| 40 | ✓ | Amicus Therapeutics INC | Stock-Other | 0.42% | — | +43.60% | |
| 41 | MDGL | Madrigal Pharmaceuticals, Inc. | Stock-Healthcare | 0.42% | — | — | |
| 42 | ZSANEUR | Zosano Pharma CORP | Stock-Other | 0.39% | — | +114.18% | |
| 43 | ✓ | Adverum Biotechnologies INC | Stock-Other | 0.37% | — | +292.48% | |
| 44 | CYTREUR | Cytrx CORP | Stock-Other | 0.36% | — | — | |
| 45 | SLNOEUR | Soleno Therapeutics INC | Stock-Other | 0.35% | — | -14.37% | |
| 46 | ✓ | Tesaro INC | Stock-Other | 0.28% | — | — | |
| 47 | ✓ | Mannkind CORP | Stock-Other | 0.28% | — | — | |
| 48 | ✓ | Esperion Therapeutics INC Ne | Stock-Other | 0.27% | — | -31.23% | |
| 49 | NOVN1EUR | Novan INC | Stock-Other | 0.26% | — | -15.09% | |
| 50 | ✓ | Pavmed INC | Stock-Other | 0.25% | — | +53.92% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Ishares Tr | +5% | +50.00% | Add |
| 2 | BIIB | Biogen Inc. | +3.9% | +18.35% | Add |
| 3 | SRPT | Sarepta Therapeutics, Inc. | +2.3% | -9.26% | Trim |
| 4 | ✓ | +1.9% | +963.21% | Add | |
| 5 | NKTREUR | Nektar Therapeutics | +1.1% | +311.22% | Add |
| 6 | ✓ | Sarepta Therapeutics INC | +1.1% | +2.25% | Add |
| 7 | BIIB | Biogen INC | +0.9% | -16.84% | Trim |
| 8 | ESPR | Esperion Therapeutics INC | +0.7% | +690.01% | Add |
| 9 | BCLIEUR | Brainstorm Cell Therapeutics | +0.6% | +4064.87% | Add |
| 10 | SSKNEUR | Strata Skin Sciences INC | +0.5% | +432.80% | Add |
| 11 | ✓ | Insmed INC | +0.5% | +205.89% | Add |
| 12 | ✓ | Odonate Therapeu | +0.1% | -21.20% | Trim |
| 13 | ✓ | Esperion Therapeutics INC Ne | -0.2% | -31.23% | Trim |
| 14 | ✓ | Zogenix INC | -0.2% | -81.51% | Trim |
| 15 | RKDAEUR | Arcadia Biosciences INC | -0.3% | -19.08% | Trim |
| 16 | INCY | Incyte CORP | -0.4% | -49.40% | Trim |
| 17 | ✓ | Spdr Series Trust | -0.4% | -55.44% | Trim |
| 18 | ✓ | -0.4% | -9.79% | Trim | |
| 19 | ✓ | Spark Therapeutics INC | -0.6% | -84.24% | Trim |
| 20 | ✓ | Zogenix INC | -0.8% | -57.55% | Trim |
| 21 | ✓ | Incyte CORP | -0.9% | -68.65% | Trim |
| 22 | ✓ | Esperion Therapeutics INC Ne | -1% | +15.45% | Add |
| 23 | AZN | AstraZeneca PLC | -1.7% | -59.84% | Trim |
| 24 | AZN | AstraZeneca PLC | -4.6% | -81.35% | Trim |
| 25 | ✓ | Spdr S&p 500 ETF Tr | -20.8% | -75.68% | Trim |
| 26 | SPY | State Street SPDR S&P 500 ETF Trust | — | NEW | New buy |
| 27 | ✓ | Ishares Tr | — | EXIT | Sold out |
| 28 | NVO | Novo Nordisk A/S | — | NEW | New buy |
| 29 | NVO | Novo-nordisk A/s-spons Adr | — | NEW | New buy |
| 30 | NVO | Novo Nordisk A/S | — | NEW | New buy |
| 31 | ✓ | Spdr Series Trust | — | NEW | New buy |
| 32 | MRK | Merck & Co., Inc. | — | EXIT | Sold out |
| 33 | SPY | Ss Spdr S&p 500 ETF Trust-us | — | EXIT | Sold out |
| 34 | ✓ | Incyte CORP | — | EXIT | Sold out |
| 35 | XERS | Xeris Biopharma Holdings, Inc. | — | NEW | New buy |
| 36 | ✓ | Alexion Pharmaceuticals INC | — | EXIT | Sold out |
| 37 | ✓ | — | NEW | New buy | |
| 38 | ✓ | Alkermes PLC | — | EXIT | Sold out |
| 39 | ✓ | Ophthotech Corporation | — | NEW | New buy |
| 40 | ABBV | AbbVie Inc. | — | EXIT | Sold out |
| 41 | ✓ | — | NEW | New buy | |
| 42 | ✓ | Alnylam Pharmaceuticals INC | — | EXIT | Sold out |
| 43 | ✓ | Galmed Pharmaceuticals LTD | — | NEW | New buy |
| 44 | AZNN | Astrazeneca Plc-spons Adr | — | NEW | New buy |
| 45 | ✓ | — | NEW | New buy | |
| 46 | MDGL | Madrigal Pharmaceuticals, Inc. | — | NEW | New buy |
| 47 | ✓ | Acceleron Pharma INC | — | EXIT | Sold out |
| 48 | CYTREUR | Cytrx CORP | — | NEW | New buy |
| 49 | ✓ | Achaogen INC | — | EXIT | Sold out |
| 50 | BMY | Bristol-Myers Squibb Company | — | EXIT | Sold out |